The Implementation of Ablative Hypofractionated Radiotherapy for Stereotactic Treatments in the Brain and Body: Observations on Efficacy and Toxicity in Clinical Practice

Lucien A. Nedzi

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Radiosurgery has a long history dating back to the 1950s. Only in the last decade or so have advances in radiation delivery and visualization allowed export of this paradigm to extracranial sites. This review evaluates the efficacy and safety of such ablative radiation courses using dose per fraction schedules of 10 Gy or above. Retrospective published experience in functional and benign tumor radiosurgery is reviewed. Prospective controlled clinical trials in ablative cancer therapy of early-stage lung cancer and metastatic disease in the brain, liver, and spine are reviewed.

Original languageEnglish (US)
Pages (from-to)265-272
Number of pages8
JournalSeminars in Radiation Oncology
Volume18
Issue number4
DOIs
StatePublished - Oct 2008

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint

Dive into the research topics of 'The Implementation of Ablative Hypofractionated Radiotherapy for Stereotactic Treatments in the Brain and Body: Observations on Efficacy and Toxicity in Clinical Practice'. Together they form a unique fingerprint.

Cite this